{
  "ptid_time": "053_S_4578_2016-03-21",
  "img_path": "/data/qiuhui/data/adni/images/053_S_4578/2016-03-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 46,932 mm³, 67.2% above the reference mean. With a Z-score of 1.54 (93.8th percentile), this represents moderate enlargement; hippocampal volume measures 8,875 mm³, 24.7% above the reference mean. With a Z-score of 2.27 (98.8th percentile), this represents significant enlargement; whole brain volume measures 1,217,810 mm³, 24.9% above the reference mean. With a Z-score of 3.14 (99.9th percentile), this represents profound enlargement; entorhinal cortex volume measures 3,440 mm³, 6.3% below the reference mean. With a Z-score of -0.39 (34.9th percentile), this represents normal volume ; fusiform gyrus volume measures 19,405 mm³, 14.1% above the reference mean. With a Z-score of 1.28 (90.0th percentile), this represents mild enlargement; middle temporal gyrus volume measures 22,403 mm³, 16.9% above the reference mean. With a Z-score of 1.46 (92.8th percentile), this represents mild enlargement. ",
  "text_data": "Age is 73.2 years. Gender is Female. Education: 14 years. MMSE: 28.0. MoCA: 25.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.17 SUVR (normal ); Total tau: 179.60 pg/mL (normal ); Phosphorylated tau: 14.95 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "Reasoning: The data shows significant enlargement in hippocampal and whole brain volumes, which is atypical for Alzheimer's disease (AD) as AD typically involves atrophy. Ventricular enlargement is moderate, but other key AD-related regions (entorhinal cortex) are normal. Cognitive scores (MMSE 28, MoCA 25) are within normal limits, and biomarkers (T-tau, P-tau, AV45) are normal. APOE4-negative status further reduces AD risk.  \n\nDiagnosis: CN (Cognitively Normal)  \nConfidence: Medium (due to unusual volumetric findings despite normal cognition and biomarkers)",
  "timestamp": "2025-07-26T07:59:45.353265"
}